Heavily pretreated breast cancer and non-small cell lung cancer patients with NECTIN4 gene amplification and/or polysomy demonstrated an enhanced response to zelenectide pevedotin Company to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback